Dudley Lab

The Dudley Lab, associated with the Department of Microbiology, Immunology and Cancer Biology (MIC), is focused on the tumor microenvironment and mechanisms of tumor neovascularization. We use transgenic tumor models, in vivo lineage tracing strategies, and endothelial cell cultures to explore differentiation and specialization of the tumor vasculature. We are also focused on how endothelial cells, and other cell types found within the tumor microenvironment such as fibroblasts, contribute to the growth, progression, and immune surveillance of solid tumors and their metastases.


Tumor blood vessel abnormalities

Tumor associated blood vessels have irregular diameters, they are fragile, leaky, and blood flow is abnormal; there is now good evidence that these abnormalities contribute to tumor growth, metastasis, and responses to different therapies.
Read More

Tumor blood vessel and tumor microenvironment heterogeneity

Endothelial cells in tumors display a spectrum of responses to TGF beta that underlies the plasticity and dysfunctional features of tumor-associated vasculature.
Read More

Mechanisms of tumor neovascularization

Solid tumors have diverse mechanisms for creating new blood vessels or utilizing the pre-existing vasculature to enable their survival.
Read More

Connect with Dudley Lab

Twitter Feed

The potential for human #organoids in medicine is growing, along with a blood supply
@NatureMedicine by @KarunaMDPhD and colleagues
@naturemethods by @IHPark5 @YaleGenetics et al


Could tiny bits of RNA help to stop a #tumor in its tracks? A recent study suggests it’s possible. Take a look. #NIH https://t.co/KanpBV5dks

Honored to learn @uvahealthnews VA Board of Visitors voted to rename the UVA Medical Center West Complex as the Collins Wing! As a proud alum I hope those who pass through are encouraged by the care, compassion&healing that lives within those walls. #NIH https://t.co/qKolBeWqVM

Let’s play a little game.

Let’s say that you’re the CSO at a cancer pharma company, and you have to choose a target to go after.

Here’s a gene – high expression is associated with poor prognosis in brain cancer. Looks like a good candidate for an inhibitor right?

Load More…